PL2850060T3 - Fluorowane pochodne zmostkowanego spiro[2.4]heptanu jako agoniści receptora alx - Google Patents
Fluorowane pochodne zmostkowanego spiro[2.4]heptanu jako agoniści receptora alxInfo
- Publication number
- PL2850060T3 PL2850060T3 PL13731938T PL13731938T PL2850060T3 PL 2850060 T3 PL2850060 T3 PL 2850060T3 PL 13731938 T PL13731938 T PL 13731938T PL 13731938 T PL13731938 T PL 13731938T PL 2850060 T3 PL2850060 T3 PL 2850060T3
- Authority
- PL
- Poland
- Prior art keywords
- receptor agonists
- heptane derivatives
- alx receptor
- bridged spiro
- fluorinated bridged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12168322 | 2012-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2850060T3 true PL2850060T3 (pl) | 2017-01-31 |
Family
ID=48699893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13731938T PL2850060T3 (pl) | 2012-05-16 | 2013-05-15 | Fluorowane pochodne zmostkowanego spiro[2.4]heptanu jako agoniści receptora alx |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9139524B2 (pl) |
| EP (1) | EP2850060B1 (pl) |
| JP (1) | JP6101789B2 (pl) |
| KR (1) | KR20150013285A (pl) |
| CN (1) | CN104321309B (pl) |
| AR (1) | AR091059A1 (pl) |
| AU (1) | AU2013261091B2 (pl) |
| BR (1) | BR112014028358A2 (pl) |
| CA (1) | CA2871336A1 (pl) |
| CL (1) | CL2014002918A1 (pl) |
| EA (1) | EA025264B1 (pl) |
| ES (1) | ES2595219T3 (pl) |
| HK (1) | HK1208441A1 (pl) |
| IL (1) | IL235660A0 (pl) |
| MA (1) | MA37618B1 (pl) |
| MX (1) | MX355221B (pl) |
| NZ (1) | NZ702971A (pl) |
| PH (1) | PH12014502465A1 (pl) |
| PL (1) | PL2850060T3 (pl) |
| SG (1) | SG11201406971WA (pl) |
| TW (1) | TWI579269B (pl) |
| WO (1) | WO2013171694A1 (pl) |
| ZA (1) | ZA201409249B (pl) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2814826C (en) | 2010-11-17 | 2019-02-12 | Actelion Pharmaceuticals Ltd | Bridged spiro[2.4]heptane ester derivatives |
| AR084172A1 (es) | 2010-12-07 | 2013-04-24 | Actelion Pharmaceuticals Ltd | Derivados aminotriazol hidroxilados como agonistas del receptor alx |
| WO2013171687A1 (en) | 2012-05-16 | 2013-11-21 | Actelion Pharmaceuticals Ltd | 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists |
| AR096686A1 (es) | 2013-06-25 | 2016-01-27 | Actelion Pharmaceuticals Ltd | Derivados de espiro[2.4]heptano puenteados sustituidos con difluoroetil-oxazol como agonistas del receptor de alx |
| JP6330038B2 (ja) * | 2013-07-18 | 2018-05-23 | イドーシア ファーマシューティカルズ リミテッドＩｄｏｒｓｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | Ａｌｘ受容体アゴニストとしてのピペラジン置換架橋スピロ［２．４］ヘプタン誘導体 |
| AR097279A1 (es) | 2013-08-09 | 2016-03-02 | Actelion Pharmaceuticals Ltd | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx |
| AP2016009502A0 (en) | 2014-05-13 | 2016-10-31 | Novartis Ag | Compounds and compositions for inducing chondrogenesis |
| JP6746614B2 (ja) | 2015-05-27 | 2020-08-26 | 杏林製薬株式会社 | ウレア誘導体、またはその薬理学的に許容される塩 |
| ES2814126T3 (es) | 2015-05-27 | 2021-03-26 | Kyorin Seiyaku Kk | Derivado de urea o sal farmacológicamente aceptable del mismo |
| CN111233751B (zh) * | 2020-03-25 | 2021-02-02 | 丽水绿氟科技有限公司 | 一种3,3-二氟-4-氨基哌啶类化合物及其衍生物的制备方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU675730B2 (en) | 1993-07-16 | 1997-02-13 | Merck & Co., Inc. | Substituted piperazinylcamphor derivatives as oxytocin antagonists |
| US20050164305A1 (en) | 2002-04-03 | 2005-07-28 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| WO2005040120A1 (en) | 2003-10-09 | 2005-05-06 | Actelion Pharmaceuticals Ltd | Tetrahydropyridine derivatives |
| BRPI0416272A (pt) | 2003-11-07 | 2007-01-09 | Acadia Pharm Inc | usos do receptor fprl1, e de compostos, uso profilático de compostos, métodos de triagem para um composto capaz de afetar uma ou mais atividades de um receptor fprl1, de tratamento ou prevenção de inflamação, de identificação de um composto de indução de vasodilatação, para antagonismo de uma resposta vasoconstrutiva a um sulfidopeptìdeo leucotrieno em um indivìduo, e para estimulação de proliferação celular em um indivìduo, e, composto |
| TW200538098A (en) | 2004-03-22 | 2005-12-01 | Astrazeneca Ab | Therapeutic agents |
| US7820699B2 (en) | 2005-04-27 | 2010-10-26 | Hoffmann-La Roche Inc. | Cyclic amines |
| WO2008121687A2 (en) | 2007-03-28 | 2008-10-09 | Array Biopharma Inc. | Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
| AR069650A1 (es) | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano |
| PL2225231T3 (pl) | 2007-12-18 | 2012-01-31 | Actelion Pharmaceuticals Ltd | Pochodne aminotriazolu jako agoniści ALX |
| DK2432760T3 (da) * | 2009-05-18 | 2013-09-08 | Actelion Pharmaceuticals Ltd | Brokoblede spiro [2.4]-heptanderivater som alx-receptor og/eller fprl2-agonister |
| US8580831B2 (en) | 2009-06-09 | 2013-11-12 | Actelion Pharmaceuticals Ltd. | Fluorinated aminotriazole derivatives |
| CA2760887A1 (en) | 2009-06-12 | 2010-12-16 | Actelion Pharmaceuticals Ltd | Oxazole and thiazole derivatives as alx receptor agonists |
| WO2011163502A1 (en) * | 2010-06-24 | 2011-12-29 | Allergan, Inc. | Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| CA2814826C (en) * | 2010-11-17 | 2019-02-12 | Actelion Pharmaceuticals Ltd | Bridged spiro[2.4]heptane ester derivatives |
| PL2649068T3 (pl) | 2010-12-07 | 2015-03-31 | Idorsia Pharmaceuticals Ltd | Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALX |
| AR084172A1 (es) | 2010-12-07 | 2013-04-24 | Actelion Pharmaceuticals Ltd | Derivados aminotriazol hidroxilados como agonistas del receptor alx |
| US8440684B2 (en) | 2011-07-11 | 2013-05-14 | Allergan, Inc. | Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| WO2013171687A1 (en) | 2012-05-16 | 2013-11-21 | Actelion Pharmaceuticals Ltd | 1-(p-tolyl)cyclopropyl substituted bridged spiro[2.4]heptane derivatives as alx receptor agonists |
| SG11201507113RA (en) | 2013-03-06 | 2015-10-29 | Allergan Inc | Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases |
| BR122017004256A2 (pt) | 2013-03-06 | 2019-09-10 | Allergan Inc | uso de agonistas do receptor de peptídeo formil 2 para tratar doenças dermatológicas |
-
2013
- 2013-05-14 MA MA37618A patent/MA37618B1/fr unknown
- 2013-05-15 MX MX2014013829A patent/MX355221B/es active IP Right Grant
- 2013-05-15 BR BR112014028358-3A patent/BR112014028358A2/pt not_active IP Right Cessation
- 2013-05-15 NZ NZ702971A patent/NZ702971A/en not_active IP Right Cessation
- 2013-05-15 WO PCT/IB2013/053976 patent/WO2013171694A1/en active Application Filing
- 2013-05-15 CA CA2871336A patent/CA2871336A1/en not_active Abandoned
- 2013-05-15 TW TW102117256A patent/TWI579269B/zh not_active IP Right Cessation
- 2013-05-15 CN CN201380025040.5A patent/CN104321309B/zh not_active Expired - Fee Related
- 2013-05-15 AR ARP130101686 patent/AR091059A1/es unknown
- 2013-05-15 EA EA201401259A patent/EA025264B1/ru not_active IP Right Cessation
- 2013-05-15 JP JP2015512184A patent/JP6101789B2/ja not_active Expired - Fee Related
- 2013-05-15 KR KR20147034766A patent/KR20150013285A/ko not_active Application Discontinuation
- 2013-05-15 EP EP13731938.0A patent/EP2850060B1/en not_active Not-in-force
- 2013-05-15 AU AU2013261091A patent/AU2013261091B2/en not_active Ceased
- 2013-05-15 US US14/401,769 patent/US9139524B2/en not_active Expired - Fee Related
- 2013-05-15 SG SG11201406971WA patent/SG11201406971WA/en unknown
- 2013-05-15 ES ES13731938.0T patent/ES2595219T3/es active Active
- 2013-05-15 PL PL13731938T patent/PL2850060T3/pl unknown
-
2014
- 2014-10-28 CL CL2014002918A patent/CL2014002918A1/es unknown
- 2014-11-05 PH PH12014502465A patent/PH12014502465A1/en unknown
- 2014-11-12 IL IL235660A patent/IL235660A0/en unknown
- 2014-12-15 ZA ZA2014/09249A patent/ZA201409249B/en unknown
-
2015
- 2015-09-14 HK HK15108959.5A patent/HK1208441A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20150118258A1 (en) | 2015-04-30 |
| KR20150013285A (ko) | 2015-02-04 |
| CN104321309A (zh) | 2015-01-28 |
| HK1208441A1 (en) | 2016-03-04 |
| WO2013171694A1 (en) | 2013-11-21 |
| CL2014002918A1 (es) | 2015-02-06 |
| EP2850060A1 (en) | 2015-03-25 |
| MA37618A1 (fr) | 2016-12-30 |
| AU2013261091B2 (en) | 2017-04-06 |
| EP2850060B1 (en) | 2016-07-13 |
| SG11201406971WA (en) | 2014-11-27 |
| CA2871336A1 (en) | 2013-11-21 |
| TW201348198A (zh) | 2013-12-01 |
| TWI579269B (zh) | 2017-04-21 |
| MX355221B (es) | 2018-04-10 |
| PH12014502465A1 (en) | 2014-12-22 |
| AR091059A1 (es) | 2014-12-30 |
| ZA201409249B (en) | 2016-09-28 |
| US9139524B2 (en) | 2015-09-22 |
| ES2595219T3 (es) | 2016-12-28 |
| MX2014013829A (es) | 2015-02-04 |
| EA201401259A1 (ru) | 2015-04-30 |
| IL235660A0 (en) | 2015-02-01 |
| MA37618B1 (fr) | 2017-08-31 |
| EA025264B1 (ru) | 2016-12-30 |
| NZ702971A (en) | 2016-09-30 |
| AU2013261091A1 (en) | 2015-01-22 |
| CN104321309B (zh) | 2016-06-22 |
| BR112014028358A2 (pt) | 2020-07-21 |
| JP6101789B2 (ja) | 2017-03-22 |
| JP2015516463A (ja) | 2015-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1208441A1 (en) | Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists alx [24] | |
| HRP20200245T1 (hr) | Postupci za pripravu (s)-1-(3-etoksi-4metoksifenil)-2-metansulfoniletilamina | |
| IL231949A0 (en) | History of [3,2,1]triazolo[5,4–d]pyrimidines as cannabinoid receptor 2 agonists | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| HK1210472A1 (en) | Spirocyclic derivatives as antiparasitic agents | |
| EP2817295A4 (en) | SUBSTITUTED 5-AMINOTHIENO- [2,3-C-] PYRIDAZINE-6-CARBOXAMIDANALOGA AS POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINACETYLCHOLIN RECEPTOR M4 | |
| ZA201601726B (en) | New octahydro-cyclobuta [1,2-c;3,4-c']dipyrrol-2-yl | |
| PL2649068T3 (pl) | Pochodne eteru oksazolilowo-metylowego jako agoniści receptora ALX | |
| EP2906063A4 (en) | GPS CONTROLLED HELMET PLATE | |
| IL250983A0 (en) | Triazolo[4, 5-d]pyrimidines as cannabinoid receptor 2 agonists | |
| HK1213559A1 (zh) | 作為 受體激動劑的吡咯並 嘧啶衍生物 | |
| HK1202546A1 (en) | Novel adamantyl derivatives as cannabinoid receptor agonists | |
| HK1207379A1 (en) | 6-aminoindole derivatives as trp channel antagonists trp 6- | |
| ZA201407696B (en) | Azetidine derivatives as antiparasitic agents | |
| PL2851075T3 (pl) | Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu | |
| PL2814825T3 (pl) | Dihydrofuranowe pochodne azetydyny jako środki przeciwpasożytnicze | |
| HK1208028A1 (en) | Novel acetamide derivatives as trp channel antagonists trp | |
| HK1200821A1 (en) | 1,2- pyridazine, 1,6- pyridazine or pyrimidine - benzamide derivatives as gpbar1 modulators gpbar1 12-16-- | |
| SG11201406582XA (en) | Intrauterine application of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one systems, intrauterine systems containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, as well as the | |
| GB201502644D0 (en) | Bicyclic aza compounds as muscarinic m1 receptor agonists | |
| AU2012903933A0 (en) | Chaz's Knotchamacallit | |
| GB201204897D0 (en) | Optimob, an optical accessory attachment system | |
| GB201219053D0 (en) | Aleshba's oil | |
| PL399603A1 (pl) | Sposób wytwarzania 3β,15α-dihydroksy-5α-androst-17-onu | |
| GB201201894D0 (en) | 'Hammerheadz' flip flops |